publication venue for
- Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey.. 10. 2023
- Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD).. 10. 2023
- Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF).. 10. 2023
- Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?. 10. 2023
- Association of body mass index with morbidity in patients hospitalised with COVID-19.. 8. 2021
- Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease.. 7. 2020
- Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.. 6. 2019
- 'It's difficult, it's life changing what happens to you', patient perspective on life with chronic hypersensitivity pneumonitis: a qualitative study. 6. 2019
- Differentiation of quantitative CT imaging phenotypes in asthma versus COPD.. 4. 2017
- Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study.. 4. 2017